Cite
MLA Citation
Juliette Sheridan et al.. “Protocol for a multicentred randomised controlled trial investigating the use of personalised golimumab dosing tailored to inflammatory load in ulcerative colitis: the GOAL-ARC study (GLM dose Optimisation to Adequate Levels to Achieve Response in Colitis) led by the INITIAtive group (NCT 0268772).” BMJ open gastroenterology, vol. 5, no. 1, 2018, p. . http://access.bl.uk/ark:/81055/vdc_100135137688.0x000002